Analysts Set Envista Holdings Co. (NYSE:NVST) Target Price at $20.13

Envista Holdings Co. (NYSE:NVST) has earned an average recommendation of “Hold” from the fifteen ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $20.13.

Several analysts have recently commented on NVST shares. Robert W. Baird raised their target price on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Wells Fargo & Company assumed coverage on shares of Envista in a research report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price objective for the company. Piper Sandler lifted their price target on Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Stifel Nicolaus increased their price target on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Leerink Partnrs raised shares of Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in NVST. Envestnet Asset Management Inc. increased its stake in Envista by 1.1% in the second quarter. Envestnet Asset Management Inc. now owns 145,877 shares of the company’s stock valued at $2,426,000 after purchasing an additional 1,648 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its stake in shares of Envista by 13.8% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 13,753 shares of the company’s stock valued at $229,000 after acquiring an additional 1,670 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Envista by 85.8% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 29,809 shares of the company’s stock worth $496,000 after acquiring an additional 13,763 shares during the period. Canada Pension Plan Investment Board boosted its position in shares of Envista by 9,626.9% in the second quarter. Canada Pension Plan Investment Board now owns 252,900 shares of the company’s stock worth $4,206,000 after acquiring an additional 250,300 shares during the last quarter. Finally, Sei Investments Co. increased its position in Envista by 20.4% during the second quarter. Sei Investments Co. now owns 925,170 shares of the company’s stock worth $15,386,000 after purchasing an additional 157,048 shares during the last quarter.

Envista Price Performance

Shares of NVST opened at $21.77 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. Envista has a 1-year low of $15.15 and a 1-year high of $24.79. The stock has a market cap of $3.75 billion, a PE ratio of -2.80, a price-to-earnings-growth ratio of 1.88 and a beta of 1.33. The firm has a fifty day moving average price of $20.05 and a 200 day moving average price of $18.91.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. The company had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Envista’s quarterly revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.43 earnings per share. As a group, sell-side analysts anticipate that Envista will post 0.72 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.